DaVita HealthCare Partners Inc (DVA)vsOncology Institute Inc (TOI)
DVA
DaVita HealthCare Partners Inc
$155.11
+1.19%
HEALTHCARE · Cap: $10.25B
TOI
Oncology Institute Inc
$3.10
-0.64%
HEALTHCARE · Cap: $288.00M
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 3115% more annual revenue ($13.64B vs $424.38M). DVA leads profitability with a 5.5% profit margin vs -15.5%. DVA earns a higher WallStSmart Score of 66/100 (B-).
DVA
Strong Buy66
out of 100
Grade: B-
TOI
Hold42
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+11.7%
Fair Value
$163.40
Current Price
$155.11
$8.29 discount
Intrinsic value data unavailable for TOI.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 65 in profit
Growing faster than its price suggests
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Revenue surging 21.5% year-over-year
Areas to Watch
5.5% margin — thin
Weak financial health signals
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -6.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : DVA
The strongest argument for DVA centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 0.56 suggests the stock is reasonably priced for its growth.
Bull Case : TOI
The strongest argument for TOI centers on Debt/Equity, Revenue Growth. Revenue growth of 21.5% demonstrates continued momentum.
Bear Case : DVA
The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.
Bear Case : TOI
The primary concerns for TOI are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
DVA profiles as a value stock while TOI is a growth play — different risk/reward profiles.
DVA carries more volatility with a beta of 0.93 — expect wider price swings.
TOI is growing revenue faster at 21.5% — sustainability is the question.
DVA generates stronger free cash flow (395M), providing more financial flexibility.
Bottom Line
DVA scores higher overall (66/100 vs 42/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Oncology Institute Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Oncology Institute Inc (ticker: TOI) is a leading healthcare organization committed to revolutionizing cancer care through its expansive network of specialized clinics and advanced treatment options. Focused on improving patient outcomes, the company utilizes cutting-edge technologies and tailored treatment strategies, while actively engaging in clinical trials and partnerships with esteemed research institutions. As the demand for innovative cancer therapies accelerates, TOI is well-positioned to capitalize on its extensive pipeline and deep oncology expertise, solidifying its role as a vital participant in the dynamic healthcare landscape.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?